1.66 USD
▼0.00-4.60%
盘后 1.73 -0.72%
2026-08-03
市值
$6.06M
市盈率
—
EPS
-1.24
股息率
—
52 周区间
1.16 – 5.58
成交量
17.32K
Beta
1.90
目标价
—
52W 低 1.1652W 高 5.58
价格走势
公司简介
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in ch...